New drug combo aims to extend life in pancreatic cancer battle
Disease control
Recruiting now
This study tests a new chemotherapy combination (paclitaxel polymeric micelles plus gemcitabine) against the current standard treatment for metastatic pancreatic cancer. About 416 adults with advanced pancreatic cancer who have not had prior treatment will take part. The goal is …
Phase: PHASE3 • Sponsor: Shanghai Yizhong Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Apr 24, 2026 16:18 UTC